Literature DB >> 11225756

Type 2 diabetes and atherosclerosis.

R Donnelly1, K R Davis.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11225756     DOI: 10.1046/j.1463-1326.2000.00019.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  6 in total

1.  Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.

Authors:  Sushil K Jain; Jennifer L Croad; Thirunavukkarasu Velusamy; Justin L Rains; Rebeca Bull
Journal:  Mol Nutr Food Res       Date:  2010-09       Impact factor: 5.914

2.  Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials.

Authors:  Atena Mahdavi; Sajjad Moradi; Gholamreza Askari; Bijan Iraj; Thozhukat Sathyapalan; Paul C Guest; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Authors:  Angela M Whetzel; David T Bolick; Catherine C Hedrick
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

Review 4.  PPARgamma and its ligands: therapeutic implications in cardiovascular disease.

Authors:  Luis Villacorta; Francisco J Schopfer; Jifeng Zhang; Bruce A Freeman; Y Eugene Chen
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

Review 5.  Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.

Authors:  Nikolas K Haass; Najah Nassif; Eileen M McGowan
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

6.  The Effects of Chromium Supplementation on Gene Expression of Insulin, Lipid, and Inflammatory Markers in Infertile Women With Polycystic Ovary Syndrome Candidate for in vitro Fertilization: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Mehrnush Amiri Siavashani; Shahrzad Zadeh Modarres; Naghmeh Mirhosseini; Esmat Aghadavod; Saghar Salehpour; Zatollah Asemi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-28       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.